Literature DB >> 6887174

Articular manifestations of primary Sjögren's syndrome.

A Castro-Poltronieri, D Alarcón-Segovia.   

Abstract

Twenty-six of 31 patients with primary Sjögren's Syndrome who had longterm followup and fulfilled strict criteria for inclusion but were otherwise unselected had articular manifestations attributable to this disease. Articular manifestations preceded sicca symptoms in 10, were simultaneous in 7, and followed sicca symptoms in 9 patients. Involvement was polyarticular in the 26, symmetric in 22, intermittent in 21, and continuous in 5. Synovitis was detected in 24, but was usually mild. These articular manifestations of primary Sjögren's syndrome were generally mild and responded readily to nonsteroidal antiinflammatory agents.

Entities:  

Mesh:

Year:  1983        PMID: 6887174

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  Sjögren syndrome in a child: favorable response of the arthritis to TNFalpha blockade.

Authors:  F Pessler; B Monash; P Rettig; B Forbes; P A Kreiger; R Q Cron
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

2.  A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren's syndrome.

Authors:  Claudia Kedor; Jan Zernicke; Anja Hagemann; Lorena Martinez Gamboa; Johanna Callhoff; Gerd-Rüdiger Burmester; Eugen Feist
Journal:  Clin Rheumatol       Date:  2016-07-28       Impact factor: 2.980

3.  Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.

Authors:  Sevil Kamali; Nuray Gurel Polat; Esen Kasapoglu; Ahmet Gul; Lale Ocal; Orhan Aral; Meral Konice; Selim Badur; Murat Inanc
Journal:  Clin Rheumatol       Date:  2005-05-31       Impact factor: 2.980

Review 4.  Methods of assessment of joint involvement in various systemic connective tissue diseases.

Authors:  Tobiasz Kardas; Ewa Wielosz; Maria Majdan
Journal:  Reumatologia       Date:  2022-02-28

5.  Leucocytoclastic vasculitis as presenting feature of primary Sjögren's syndrome.

Authors:  H M Markusse; M Schoonbrood; M Oudkerk; S C Henzen-Logmans
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

6.  Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.

Authors:  E J ter Borg; J C Kelder
Journal:  Clin Rheumatol       Date:  2016-01-20       Impact factor: 2.980

7.  The diagnostic value of salivary fluid levels of beta 2-microglobulin, lysozyme and lactoferrin for primary Sjögren's syndrome.

Authors:  H M Markusse; H G Otten; T M Vroom; T J Smeets; N Fokkens; F C Breedveld
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

8.  Atypical erosive osteoarthritis and Sjögren's syndrome.

Authors:  R Shuckett; M L Russell; D D Gladman
Journal:  Ann Rheum Dis       Date:  1986-04       Impact factor: 19.103

9.  Follow-up of primary Sjogren's syndrome patients presenting positive anti-cyclic citrullinated peptides antibody.

Authors:  Yang-Seon Ryu; Sung-Hwan Park; Jennifer Lee; Seung-Ki Kwok; Ji-Hyeon Ju; Ho-Youn Kim; Chan-Hong Jeon
Journal:  Rheumatol Int       Date:  2012-11-21       Impact factor: 2.631

10.  Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis.

Authors:  Fabiola Atzeni; Piercarlo Sarzi-Puttini; Nicola Lama; Eleonora Bonacci; Francesca Bobbio-Pallavicini; Carlomaurizio Montecucco; Roberto Caporali
Journal:  Arthritis Res Ther       Date:  2008-05-07       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.